Westpac Banking Corp Biogen Inc. Transaction History

Westpac Banking Corp

  • $1.49 Trillion
  • Q3 2024

A detailed history of Westpac Banking Corp transactions in Biogen Inc. stock. As of the latest transaction made, Westpac Banking Corp holds 2,149 shares of BIIB stock, worth $323,725. This represents 0.03% of its overall portfolio holdings.

Number of Shares
2,149
Previous 1,906 12.75%
Holding current value
$323,725
Previous $442 Million 5.72%
% of portfolio
0.03%
Previous 0.04%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024
BUY
$189.07 - $236.8 $45,944 - $57,542
243 Added 12.75%
2,149 $417 Million
Q2 2024

Aug 14, 2024
BUY
$190.52 - $236.72 $318,930 - $396,269
1,674 Added 721.55%
1,906 $442 Million
Q2 2024

Aug 12, 2024
SELL
$190.52 - $236.72 $318,930 - $396,269
-1,674 Reduced 87.83%
232 $442 Million
Q1 2024

May 09, 2024
SELL
$212.02 - $267.71 $4,028 - $5,086
-19 Reduced 0.99%
1,906 $411 Million
Q4 2023

Feb 08, 2024
BUY
$222.59 - $267.94 $60,099 - $72,343
270 Added 16.31%
1,925 $498 Million
Q3 2023

Nov 09, 2023
BUY
$253.3 - $285.89 $49,646 - $56,034
196 Added 13.43%
1,655 $425 Million
Q2 2023

Aug 10, 2023
SELL
$275.25 - $318.06 $3.97 Million - $4.58 Million
-14,406 Reduced 90.8%
1,459 $416 Million
Q1 2023

May 03, 2023
SELL
$256.56 - $292.34 $594,449 - $677,351
-2,317 Reduced 12.74%
15,865 $4.41 Billion
Q4 2022

Feb 06, 2023
SELL
$252.44 - $306.72 $165,095 - $200,594
-654 Reduced 3.47%
18,182 $5.03 Billion
Q3 2022

Nov 08, 2022
SELL
$194.69 - $268.46 $5.63 Million - $7.76 Million
-28,900 Reduced 60.54%
18,836 $5.03 Billion
Q2 2022

Aug 10, 2022
BUY
$187.54 - $223.02 $51,948 - $61,776
277 Added 0.58%
47,736 $9.74 Billion
Q1 2022

May 11, 2022
SELL
$193.77 - $244.14 $1.06 Million - $1.34 Million
-5,471 Reduced 10.34%
47,459 $9.99 Million
Q4 2021

Feb 08, 2022
BUY
$223.92 - $287.77 $6.82 Million - $8.77 Million
30,475 Added 135.72%
52,930 $12.7 Billion
Q3 2021

Oct 27, 2021
SELL
$282.99 - $369.05 $1.02 Million - $1.33 Million
-3,609 Reduced 13.85%
22,455 $6.35 Million
Q2 2021

Aug 11, 2021
SELL
$259.0 - $414.71 $1.4 Million - $2.24 Million
-5,396 Reduced 17.15%
26,064 $9.03 Million
Q1 2021

May 13, 2021
BUY
$242.95 - $284.63 $305,874 - $358,349
1,259 Added 4.17%
31,460 $8.8 Million
Q4 2020

Feb 11, 2021
SELL
$236.26 - $355.63 $5.61 Million - $8.45 Million
-23,756 Reduced 44.03%
30,201 $7.4 Million
Q3 2020

Nov 10, 2020
SELL
$264.77 - $305.71 $2.53 Million - $2.93 Million
-9,569 Reduced 15.06%
53,957 $15.3 Million
Q2 2020

Aug 12, 2020
BUY
$258.66 - $342.55 $1.12 Million - $1.48 Million
4,316 Added 7.29%
63,526 $17 Million
Q1 2020

May 14, 2020
BUY
$268.85 - $341.04 $3.63 Million - $4.6 Million
13,496 Added 29.52%
59,210 $18.7 Million
Q4 2019

Feb 11, 2020
SELL
$220.06 - $304.07 $6.28 Million - $8.68 Million
-28,550 Reduced 38.44%
45,714 $13.6 Million
Q3 2019

Nov 13, 2019
SELL
$217.44 - $243.88 $2.88 Million - $3.23 Million
-13,224 Reduced 15.12%
74,264 $17.3 Million
Q2 2019

Aug 01, 2019
BUY
$219.29 - $241.72 $1.93 Million - $2.13 Million
8,816 Added 11.21%
87,488 $0
Q1 2019

May 14, 2019
BUY
$216.71 - $338.96 $3.15 Million - $4.93 Million
14,536 Added 22.66%
78,672 $0
Q4 2018

Feb 07, 2019
BUY
$278.5 - $352.75 $471,779 - $597,558
1,694 Added 2.71%
64,136 $19.3 Million
Q3 2018

Nov 13, 2018
BUY
$293.51 - $383.83 $12.8 Million - $16.7 Million
43,570 Added 230.87%
62,442 $0
Q1 2018

May 01, 2018
BUY
$260.13 - $367.91 $1.26 Million - $1.78 Million
4,843 Added 34.52%
18,872 $0
Q3 2017

Oct 30, 2017
BUY
$281.15 - $329.69 $3.94 Million - $4.63 Million
14,029
14,029 $0

Others Institutions Holding BIIB

# of Institutions
1,038
Shares Held
126M
Call Options Held
1.13M
Put Options Held
1.43M
View Full List

About BIOGEN INC.

BIIB Quotes by TradingView
  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Westpac Banking Corp Portfolio

Follow Westpac Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westpac Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Westpac Banking Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email